|
US4599152A
(en)
|
1985-05-24 |
1986-07-08 |
Albion Laboratories |
Pure amino acid chelates
|
|
US4863898A
(en)
|
1986-02-06 |
1989-09-05 |
Albion International, Inc. |
Amino acid chelated compositions for delivery to specific biological tissue sites
|
|
US4883658A
(en)
|
1986-04-28 |
1989-11-28 |
Holly Frank J |
Ophthalmic solution for treatment of dry-eye syndrome
|
|
US4804539A
(en)
|
1986-07-28 |
1989-02-14 |
Liposome Technology, Inc. |
Ophthalmic liposomes
|
|
US4914088A
(en)
|
1987-04-02 |
1990-04-03 |
Thomas Glonek |
Dry eye treatment solution and method
|
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
|
US5061815A
(en)
|
1988-07-06 |
1991-10-29 |
Zinpro Corporation |
Metal lysine complexes and method for producing metal lysine complexes
|
|
US5075104A
(en)
|
1989-03-31 |
1991-12-24 |
Alcon Laboratories, Inc. |
Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
|
|
EP0459148B1
(en)
|
1990-05-29 |
1996-01-03 |
Ocular Research Of Boston Inc. |
Dry eye treatment composition
|
|
ZA912797B
(en)
|
1990-05-29 |
1992-12-30 |
Boston Ocular Res |
Dry eye treatment process and solution
|
|
ZA927277B
(en)
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
|
US6048897A
(en)
|
1993-06-15 |
2000-04-11 |
Brigham And Women's Hospital |
Lipoxin compounds and their use in treating cell proliferative disorders
|
|
US5441951A
(en)
|
1994-06-15 |
1995-08-15 |
Brigham & Women's Hospital |
Lipoxin compounds
|
|
US6887901B1
(en)
|
1993-06-15 |
2005-05-03 |
Brigham & Women's Hospital, Inc. |
Lipoxin compounds and their use in treating cell proliferative disorders
|
|
IT1264987B1
(it)
|
1993-12-14 |
1996-10-17 |
Prospa Bv |
Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
|
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
FR2774591B1
(fr)
|
1998-02-12 |
2000-05-05 |
Lipha |
Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
|
|
US6517870B1
(en)
|
1998-04-29 |
2003-02-11 |
Sumitomo Pharmaceuticals Company, Limited |
Oral formulation comprising biguanide and an organic acid
|
|
JP4526622B2
(ja)
|
1998-10-23 |
2010-08-18 |
北興化学工業株式会社 |
農園芸用種子消毒剤および種子の消毒方法
|
|
JP2000212145A
(ja)
|
1999-01-22 |
2000-08-02 |
Hokko Chem Ind Co Ltd |
Ｎε―アシル―４―オキサリジンおよびその製造用中間体
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
KR100784752B1
(ko)
|
2000-02-04 |
2007-12-13 |
다케다 야쿠힌 고교 가부시키가이샤 |
안정한 에멀젼 조성물
|
|
EP1762557B1
(en)
|
2000-02-16 |
2011-04-06 |
The Brigham And Women's Hospital, Inc. |
Aspirin-triggered lipid mediators
|
|
US6491950B1
(en)
|
2000-08-07 |
2002-12-10 |
Kos Pharmaceuticals, Inc. |
Controlled release pharmaceutical composition
|
|
US6667064B2
(en)
|
2000-08-30 |
2003-12-23 |
Pilot Therapeutics, Inc. |
Composition and method for treatment of hypertriglyceridemia
|
|
US6689385B2
(en)
|
2000-11-03 |
2004-02-10 |
Chronorx Llc |
Formulations for the treatment of insulin resistance and type 2 diabetes mellitus
|
|
DE10102050A1
(de)
|
2001-01-17 |
2002-07-18 |
Basf Ag |
Zubereitung zur Verbesserung der Nahrungsverwertung
|
|
WO2002070068A2
(en)
|
2001-03-02 |
2002-09-12 |
The Brigham And Women's Hospital |
Lipoxin analogs as novel inhibitors of angiogenesis
|
|
WO2002079139A1
(de)
|
2001-03-29 |
2002-10-10 |
Basf Aktiengesellschaft |
Konjugierte ungesättigte glyceridgemische und verfahren zur ihrer herstellung
|
|
DE60234780D1
(de)
|
2001-08-31 |
2010-01-28 |
Univ Rutgers |
Verfahren zur behandlung von krankheiten mit pflanzenextrakten
|
|
US20030166716A1
(en)
|
2001-11-06 |
2003-09-04 |
Serhan Charles N. |
Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
|
|
ITMI20012384A1
(it)
|
2001-11-12 |
2003-05-12 |
Quatex Nv |
Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
|
|
WO2003068209A1
(en)
|
2002-02-14 |
2003-08-21 |
Sonus Pharmaceuticals, Inc. |
Metformin salts of lipophilic acids
|
|
US7670612B2
(en)
|
2002-04-10 |
2010-03-02 |
Innercap Technologies, Inc. |
Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
|
|
CA2487274A1
(en)
|
2002-05-06 |
2003-11-13 |
Nucleonics Inc. |
Spermine chemically linked to lipids and cell-specific targeting molecules as a transfection agent
|
|
JP2005529945A
(ja)
|
2002-06-17 |
2005-10-06 |
リソルヴィックス ファーマシューティカルズ |
オメガ−３ｐｕｆａ由来の脂質メディエーターの類似体及び使用方法
|
|
US7399488B2
(en)
|
2002-07-05 |
2008-07-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
|
JP2005537298A
(ja)
|
2002-08-02 |
2005-12-08 |
ペンウェスト ファーマシューティカルズ カンパニー |
メトホルミンの徐放性製剤
|
|
US7759395B2
(en)
|
2002-08-12 |
2010-07-20 |
The Brigham And Women's Hospital, Inc. |
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
|
|
EP2384750A1
(en)
|
2002-09-27 |
2011-11-09 |
Martek Biosciences Corporation |
Improved Glycemic Control for Prediabetes and/or Diabetes Type II using Docohexaenoic Acid
|
|
US7547454B2
(en)
|
2002-11-07 |
2009-06-16 |
Shyam K Gupta |
Hydroxy acid complexes for antiaging and skin renovation
|
|
JP2004175790A
(ja)
|
2002-11-12 |
2004-06-24 |
Arita Junichi |
α−グルコシダーゼ阻害作用を有する亜鉛含有物
|
|
ITMI20022394A1
(it)
|
2002-11-13 |
2004-05-14 |
Bracco Spa |
Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
|
|
MXPA05009933A
(es)
|
2003-03-18 |
2005-11-04 |
Novartis Ag |
Composiciones que comprenden acidos grasos y aminoacidos.
|
|
WO2004091578A2
(en)
|
2003-04-09 |
2004-10-28 |
Biodelivery Sciences International, Inc. |
Novel encochleation methods, cochleates and methods of use
|
|
EP1510208A1
(en)
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Pharmaceutical composition comprising a combination of metformin and statin
|
|
WO2005042539A1
(en)
|
2003-10-29 |
2005-05-12 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US20080045559A1
(en)
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
KR20060108692A
(ko)
|
2003-10-31 |
2006-10-18 |
알자 코포레이션 |
메트포르민의 개선된 흡수를 위한 조성물 및 제형
|
|
EP1708707A1
(en)
|
2004-01-22 |
2006-10-11 |
Neurosearch A/S |
Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
|
|
GB0403247D0
(en)
|
2004-02-13 |
2004-03-17 |
Tillotts Pharma Ag |
A pharmaceutical composition
|
|
EP1591114A1
(en)
|
2004-03-12 |
2005-11-02 |
Fournier Laboratories Ireland Limited |
Use of metformin and orlistat for the treatment or prevention of obesity
|
|
WO2005118612A1
(en)
|
2004-06-04 |
2005-12-15 |
Sonus Pharmaceuticals, Inc. |
Cholesterol/bile acid/bile acid derivative-modified therapeutic anti-cancer drugs
|
|
TWI236573B
(en)
|
2004-07-09 |
2005-07-21 |
Asia Optical Co Inc |
Camera lens with adjustment mechanism
|
|
WO2006046156A2
(en)
|
2004-10-29 |
2006-05-04 |
Joan Campbell-Tofte |
Anti-diabetic extract isolated from rauvolfia vomitoria and citrus aurantium, and methods of using same
|
|
US20060293288A1
(en)
|
2005-01-07 |
2006-12-28 |
Serhan Charles N |
Use of resolvins to treat gastrointestinal diseases
|
|
WO2006117668A1
(en)
|
2005-05-04 |
2006-11-09 |
Pronova Biopharma Norge As |
Fatty acid analogues, i.e. dha derivatives for uses as a medicament
|
|
US20080200533A1
(en)
|
2005-07-04 |
2008-08-21 |
Ramu Krishnan |
Drug or Pharmaceutical Compounds and a Preparation Thereof
|
|
WO2007041440A2
(en)
|
2005-10-03 |
2007-04-12 |
The Brigham And Women's Hospital, Inc. |
Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers
|
|
EP1960356A2
(en)
|
2005-11-03 |
2008-08-27 |
Ilypsa, Inc. |
Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
|
|
EP1984355A2
(en)
|
2006-02-16 |
2008-10-29 |
Takeda Pharmaceutical Company Limited |
Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
|
|
US20090047340A1
(en)
|
2006-03-29 |
2009-02-19 |
Guilford F Timothy |
Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis
|
|
WO2007149313A1
(en)
|
2006-06-16 |
2007-12-27 |
Indigene Pharmaceuticals Inc. |
Metformin r-(+) lipoate as an antidiabetic agent for control of diabetic hyperglycemia and diabetic complications
|
|
US20120189569A1
(en)
|
2006-08-06 |
2012-07-26 |
Bioderm Research |
Hydroxy Acid Complexes for Skin Renovation and Clarity
|
|
TW200816991A
(en)
*
|
2006-08-23 |
2008-04-16 |
Bayer Schering Pharma Ag |
Treatment and prevention of intestinal fibrosis
|
|
KR101438177B1
(ko)
|
2006-11-01 |
2014-09-05 |
프로노바 바이오파마 너지 에이에스 |
페록시솜 증식자-활성화 수용체의 활성자 또는 조절자인 알파-치환된 오메가-3 지질
|
|
US20100105773A1
(en)
|
2006-11-09 |
2010-04-29 |
The Children's Medical Center Corporation |
Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization
|
|
PE20081200A1
(es)
*
|
2006-12-04 |
2008-11-06 |
Bayer Schering Pharma Ag |
Sal de potasio cristalina de analogos de lipoxina a4
|
|
CN105152983A
(zh)
|
2007-01-29 |
2015-12-16 |
韩诺生物制药株式会社 |
N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
|
|
US20090227560A1
(en)
|
2007-04-27 |
2009-09-10 |
Takanobu Kuroita |
Substituted imidazole compound and use thereof
|
|
TW200904433A
(en)
|
2007-04-27 |
2009-02-01 |
Takeda Pharmaceutical |
Substituted imidazole compound and use thereof
|
|
US20090054513A1
(en)
|
2007-08-22 |
2009-02-26 |
Response Scientific, Inc. |
Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
|
|
CN101855204B
(zh)
|
2007-09-21 |
2013-09-11 |
韩兀生物制药株式会社 |
N,n-二甲基亚氨二羰酸二酰胺二羧酸盐、其制备方法及其药物组合物
|
|
WO2009051112A1
(ja)
|
2007-10-15 |
2009-04-23 |
Takeda Pharmaceutical Company Limited |
アミド化合物およびその用途
|
|
US20110046053A1
(en)
|
2008-05-05 |
2011-02-24 |
Oramed Ltd. |
Methods and compositions for oral administration of exenatide
|
|
NZ600238A
(en)
|
2008-06-19 |
2014-04-30 |
Takeda Pharmaceutical |
Heterocyclic compound and use thereof
|
|
AU2008357111B2
(en)
|
2008-06-26 |
2013-05-09 |
Laboratorios Silanes, S.A. De C.V. |
A new metformin Glycinate salt for blood glucose control
|
|
FR2934519B1
(fr)
|
2008-08-01 |
2013-06-28 |
Oreal |
Procede de fabrication d'un premier recipient de produit cosmetique, moule, col et recipient associes
|
|
SG175390A1
(en)
|
2009-04-29 |
2011-12-29 |
Amarin Corp Plc |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
|
CN106074486A
(zh)
|
2009-06-15 |
2016-11-09 |
阿马里纳药物爱尔兰有限公司 |
在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl‑c水平的组合物和方法
|
|
WO2011034887A2
(en)
|
2009-09-15 |
2011-03-24 |
The Brigham And Women's Hospital, Inc. |
A method for treating neuropathic pain
|
|
PL217815B1
(pl)
|
2009-12-14 |
2014-08-29 |
Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością |
Napój izotoniczny z chelatami
|
|
US8178707B2
(en)
|
2010-03-25 |
2012-05-15 |
Jost Chemical Company |
Co-precipitated salts of fatty acids
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
US8796338B2
(en)
|
2011-01-07 |
2014-08-05 |
Elcelyx Therapeutics, Inc |
Biguanide compositions and methods of treating metabolic disorders
|
|
US20120178813A1
(en)
|
2011-01-12 |
2012-07-12 |
Thetis Pharmaceuticals Llc |
Lipid-lowering antidiabetic agent
|
|
WO2012141316A1
(ja)
|
2011-04-13 |
2012-10-18 |
味の素株式会社 |
栄養組成物
|
|
RS57777B1
(sr)
|
2012-01-06 |
2018-12-31 |
Omthera Pharmaceuticals Inc |
Dpa-obogaćene kompozicije omega-3 polinezasićenih masnih kiselina u obliku slobodne kiseline
|
|
EP2823311B1
(en)
|
2012-03-06 |
2016-04-27 |
Life Technologies Corporation |
Biomarkers for systemic lupus erythematosus
|
|
DK2858496T3
(da)
|
2012-05-10 |
2023-07-24 |
Solutex Na Llc |
Olier med anti-inflammatorisk aktivitet, som indeholder naturlige specialiserede pro-afhjælpningsmediatorer og deres forløbere
|
|
EP2861227A4
(en)
|
2012-06-17 |
2016-01-27 |
Matinas Biopharma Inc |
OMEGA-3 PENTAIC ACID COMPOSITIONS AND METHODS OF USE
|
|
US20140011814A1
(en)
|
2012-07-06 |
2014-01-09 |
Thetis Pharmaceuticals Llc |
Diamine and meglumine salt forms of fatty acids
|
|
US8765811B2
(en)
|
2012-07-10 |
2014-07-01 |
Thetis Pharmaceuticals Llc |
Tri-salt form of metformin
|
|
CN104684889A
(zh)
|
2012-07-10 |
2015-06-03 |
西蒂斯制药有限责任公司 |
二甲双胍的三盐形式
|
|
WO2014011895A2
(en)
|
2012-07-11 |
2014-01-16 |
Thetis Pharmaceuticals Llc |
High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof
|
|
AU2012227298B2
(en)
|
2012-09-25 |
2015-02-12 |
Jost Chemical Co. |
Co-precipitated salts of fatty acids
|
|
TW201416726A
(zh)
|
2012-10-26 |
2014-05-01 |
Dongguan Masstop Liquid Crystal Display Co Ltd |
具有觸控功能之彩色濾光片基板
|
|
US9394318B2
(en)
|
2012-11-30 |
2016-07-19 |
Cypress Pharmaceuticals, Inc. |
Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
|
|
CN103340300A
(zh)
|
2013-06-06 |
2013-10-09 |
李才平 |
一种绿色生态鲫鱼饲料的配制方法
|
|
CA2947741A1
(en)
*
|
2014-05-05 |
2015-11-12 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to ionic salts of peptides
|
|
US9242008B2
(en)
*
|
2014-06-18 |
2016-01-26 |
Thetis Pharmaceuticals Llc |
Mineral amino-acid complexes of fatty acids
|
|
US9999626B2
(en)
*
|
2014-06-18 |
2018-06-19 |
Thetis Pharmaceuticals Llc |
Mineral amino-acid complexes of active agents
|
|
CN104430341B
(zh)
|
2014-12-10 |
2016-09-28 |
青岛大学 |
天然有机酸根褐藻氨酸螯合物在农用制剂中的应用
|
|
US10653703B2
(en)
|
2015-09-03 |
2020-05-19 |
Solutex Na Llc |
Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same
|
|
GB201522132D0
(en)
|
2015-12-15 |
2016-01-27 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
ES2827796T3
(es)
|
2016-06-03 |
2021-05-24 |
Thetis Pharmaceuticals Llc |
Composiciones y procedimientos relativos a sales de mediadores pro-resolutivos especializados de inflamación
|